- Adherence among chronic disease patients can lead to big savings
- Novo Nordisk's Victoza helps patients achieve blood-sugar control when switching from exenatide or sitagliptin
- Novo Nordisk wins 2010 Good Design Award for NovoPen Echo
- Sanofi presents study data at American Diabetes Association’s 71st Scientific Sessions
- Fatty liver may impose diabetes risk
FRANKLIN LAKES, N.J. — Medical supply manufacturer BD has released a syringe with a shorter needle designed to reduce discomfort in patients with diabetes who must inject insulin, the company said Tuesday.
BD announced the introduction of the ultra-fine 6mm needle, saying more than 80% of patients expressed a preference for it in trials, and a recent article published by the American Association of Diabetes Educators recognized the safety and efficacy of shorter needles.
The needle is designed to deliver insulin subcutaneously in adults and children.